Newsletter Archive

11. 03.14.23 -- Top Pharma Continues To Choose A Unified Platform Approach In 2023 3/14/2023

    03/14/23 Clinical Leader Newsletter

12. 03.13.23 -- Pfizer Exec On Pharma's Role In Improving Health Literacy 3/13/2023
    03/13/23 Clinical Leader Newsletter
13. 03.10.23 -- FDA Guidance Addresses Data Considerations For Externally Controlled Trials 3/10/2023
    03/10/23 Clinical Leader Newsletter
14. 03.10.23 -- Partners Ready To Support Your Phase I-III Trials 3/10/2023
    03/10/23 Clinical Leader Newsletter
15. 03.09.23 -- FDA Vs. EMA: Comparing Cell & Gene Therapy Requirements 3/9/2023
    03/09/23 Clinical Leader Newsletter
16. 03.09.23 -- Efficient Clinical Supply Management And Forecasting 3/9/2023

    03/09/23 Clinical Leader Newsletter

17. 03.08.23 -- Walgreens Exec: “Optionality” Is The Way Forward For Hybrid Trials 3/8/2023
    03/08/23 Clinical Leader Newsletter
18. 03.07.23 -- Questions Sponsors Should Ask When Selecting Tech Vendors For DCTs 3/7/2023
    03/07/23 Clinical Leader Newsletter
19. 03.07.23 -- A New Solution For Multisite Research 3/7/2023

    03/07/23 Clinical Leader Newsletter

20. 03.06.23 -- Are DCTs Saving Sites Money? [Video] 3/6/2023
    03/06/23 Clinical Leader Newsletter